Eisai
4523.T
#2275
Rank
A$12.40 B
Marketcap
A$43.95
Share price
3.58%
Change (1 day)
-5.73%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): A$1.31

According to Eisai's latest financial reports the company's current EPS (TTM) is A$1.23. In 2026 the company made an earnings per share (EPS) of A$1.22 a decrease over its 2025 EPS that were of A$1.54.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2026A$1.22-21.04%
2025A$1.5411.85%
2024A$1.38-32.63%
2023A$2.055.52%
2022A$1.94-74.01%
2021A$7.48-66.58%
2020A$22.3698.24%
2019A$11.2817.01%
2018A$9.6437.78%
2017A$7.00-27.62%
2016A$9.6735.33%
2015A$7.14-2.82%
2014A$7.35-27.66%
2013A$10.16-27.49%
2012A$14.02-12.67%
2011A$16.0588.08%
2010A$8.53-11.06%
2009A$9.60-390.15%
2008A-$3.31-127.78%
2007A$11.91347.11%
2006A$2.664.38%
2005A$2.557.4%
2004A$2.3843.03%
2003A$1.6625.09%
2002A$1.3352.67%
2001A$0.8769.76%
2000A$0.51